CSIMarket
Company Name or Ticker Symbol
Search for oher Categories
 

Healthcare Sector

Biotechnology & Drugs Industry  


Data by Company within Biotechnology & Drugs Industry


  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Allergan Plc $ 85,052 $ 14,348 $ 12,159 10,500
Amgen Inc. $ 127,180 $ 23,050 $ 8,174 17,900
Biogen Inc. $ 60,751 $ 11,717 $ 3,288 7,550
Gilead Sciences Inc $ 99,356 $ 28,600 $ 11,595 7,000
Abbvie Inc. $ 114,342 $ 26,218 $ 6,310 26,000
Emergent Biosolutions Inc. $ 1,792 $ 495 $ 58 -
Agenus Inc $ 419 $ 44 $ -112 -
Albany Molecular Research Inc $ 929 $ 629 $ -71 -
Alder Biopharmaceuticals Inc $ 537 - $ -223 -
Biotime Inc $ 300 $ 4 $ 90 -
Ds Healthcare Group, Inc. $ 2 $ 12 $ -6 105
Enzon Pharmaceuticals, Inc. $ 17 $ 7 $ -2 -
La Jolla Pharmaceutical Co $ 714 - $ 0 -
Nanostring Technologies Inc $ 337 $ 90 $ -51 -
Neurocrine Biosciences Inc $ 4,262 - $ -200 -
Novavax Inc $ 280 $ 17 $ -247 -
Atyr Pharma Inc $ 80 - $ -55 -
Organovo Holdings, Inc. $ 245 $ 4 $ -38 -
Pdl Biopharma, Inc. $ 400 $ 187 $ 75 -
Vistagen Therapeutics, Inc. $ 10 - $ -45 -
Cel Sci Corp $ 399 - $ -10 -
Heska Corp $ 793 $ 133 $ 15 -
Sangamo Therapeutics, Inc $ 625 $ 19 $ -72 -
Bio-techne Corp $ 4,362 $ 541 $ 70 -
Pluristem Therapeutics Inc $ 107 - $ -27 -
Multicell Technologies, Inc. $ 1 $ 1 $ 0 -
Protalix Biotherapeutics, Inc. $ 89 $ 11 $ -80 -
Bohai Pharmaceuticals Group, Inc. $ 7 $ 175 $ 22 -
Cellceutix Corp $ 107 - $ -14 -
Shengtai Pharmaceutical, Inc. $ 0 - $ 0 -
Tongli Pharmaceuticals (usa), Inc. $ 1 - $ 0 -
Intellect Neurosciences, Inc. $ 0 - $ 2 -
Adma Biologics, Inc. $ 47 $ 11 $ -21 -
Anavex Life Sciences Corp. $ 172 $ 0 $ -13 -
Momenta Pharmaceuticals Inc $ 1,136 $ 116 $ -29 -
Acorda Therapeutics Inc $ 994 $ 523 $ -54 -
Vical Inc $ 29 $ 13 $ -9 -
Hubei Minkang Pharmaceutical Ltd. $ 0 $ 10 $ -1 -
Microchannel Technologies Corp $ 0 - $ 0 -
Cellular Biomedicine Group, Inc. $ 139 $ 0 $ -30 -
Intelgenx Technologies Corp. $ 54 $ 6 $ -1 -
Nutrastar International Inc. $ 0 $ 44 $ 23 -
China Biologic Products, Inc. $ 2,771 $ 347 $ 130 -
Mateon Therapeutics Inc $ 19 - $ -14 -
Repligen Corp $ 1,400 $ 110 $ 13 -
Microbot Medical Inc. $ 42 - $ -1 -
Repros Therapeutics Inc. $ 9 $ 0 $ -18 -
Biota Pharmaceuticals, Inc. $ 60 $ 13 $ -32 -
Idera Pharmaceuticals, Inc. $ 273 $ 16 $ -41 -
Halozyme Therapeutics Inc. $ 1,666 $ 134 $ -116 -
Biocryst Pharmaceuticals Inc $ 383 $ 31 $ -47 -
Savient Pharmaceuticals Inc $ 2,951 $ 21 $ -110 -
Ridgefield Acquisition Corp $ 1 - $ 0 -
Curis Inc $ 278 $ 8 $ -67 -
Seattle Genetics Inc $ 7,546 $ 416 $ -180 -
Health Discovery Corp $ 2 $ 0 $ -2 -
Capstone Therapeutics Corp. $ 3 - $ 2 -
Ariad Pharmaceuticals Inc $ 4,635 $ 186 $ -32 -
Diffusion Pharmaceuticals Inc. $ 19 - $ -40 -
Arno Therapeutics, Inc $ 3 - $ -10 -
Beesfree, Inc. $ 0 - $ -1 -
Oncovista Innovative Therapies, Inc $ 0 - $ -3 -
Lion Biotechnologies, Inc. $ 433 - $ -67 -
Cadus Corp $ 26 - $ -1 -
Neuralstem, Inc. $ 19 $ 0 $ -22 -
Lixte Biotechnology Holdings, Inc. $ 8 - $ -2 -
Brainstorm Cell Therapeutics Inc. $ 87 - $ -5 -
Champions Oncology, Inc. $ 28 $ 15 $ -7 -
Hemispherx Biopharma Inc $ 11 $ 0 $ -8 -
Medgenics, Inc. $ 186 - $ -46 -
Vericel Corp $ 108 $ 50 $ -26 -
Noho, Inc. $ 0 $ 1 $ -6 -
Ophthalix, Inc. $ 1 - $ 1 -
Protokinetix, Inc. $ 12 - $ -2 -
Apollo Endosurgery, inc. $ 31 $ 79 $ -47 -
Osiris Therapeutics, Inc. $ 232 $ 134 $ 1 -
Cytrx Corp $ 65 - $ -49 -
Hst Global, Inc. $ 0 - $ 0 -
Lescarden Inc $ 2 $ 0 $ 0 -
Green Planet Bio Engineering Co. Ltd. $ 1 - $ 0 -
Amarantus Bioscience Holdings, Inc. $ 1 - $ -39 -
Empowered Products, Inc. $ 0 $ 4 $ -1 -
Biorestorative Therapies, Inc. $ 16 $ 0 $ -9 -
American Bio Medica Corp $ 3 $ 5 $ 0 -
Eastgate Biotech Corp $ 0 $ 0 $ -3 -
Genethera Inc $ 0 - $ -1 -
Orgenesis Inc. $ 56,262 $ 11 $ 1 -
Amarillo Biosciences Inc $ 6 - $ -1 -
Chromadex Corp. $ 135 $ 24 $ -5 -
Regenerx Biopharmaceuticals Inc $ 37 $ 0 $ 4 -
Burzynski Research Institute Inc $ 8 - $ -2 -
Trovagene, Inc. $ 29 $ 0 $ -39 -
Northsight Capital, Inc. $ 6 $ 0 $ -1 -
Cellcyte Genetics Corp. $ 0 - $ 0 -
American Cryostem Corp $ 23 $ 1 $ -2 -
Intellicell Biosciences, Inc. $ 0 - $ -11 -
Procyon Corporation $ 2 $ 4 $ 0 -
Delmar Pharmaceuticals, Inc. $ 9 - $ 2 -
Innovus Pharmaceuticals, Inc. $ 15 $ 7 $ -15 -
Entest Biomedical, Inc. $ 2 - $ 0 -
Rich Pharmaceuticals, Inc. $ 1 - $ -1 -
Sunwin Stevia International, Inc. $ 20 - $ 2 -
Myrexis, Inc. - - $ -12 -
Tg Therapeutics, Inc. $ 614 $ 0 $ -92 -
Marina Biotech, Inc. $ 35 - $ -3 -
Nutra Pharma Corp. $ 0 $ 0 $ -3 -
Cytodyn Inc. $ 109 - $ -26 -
Sun Biopharma, Inc. $ 33 - $ -10 -
Galena Biopharma, Inc. $ 15 - $ -19 -
Windtree Therapeutics Inc $ 29 $ 1 $ -57 -
Gtx Inc $ 91 - $ -26 -
Biopharmx Corp $ 24 $ 0 $ -19 -
Teligent, Inc. $ 419 $ 71 $ -10 -
Bluebird Bio, Inc. $ 3,914 $ 11 $ -276 -
Diadexus, Inc. $ 0 $ 16 $ -8 -
Regen Biopharma Inc $ 3 - $ -4 -
Nanoantibiotics, Inc. $ 11 - $ 0 -
Targeted Medical Pharma, Inc. $ 0 $ 5 $ -3 -
Asterias Biotherapeutics, Inc. $ 172 $ 7 $ -31 -
Acceleron Pharma Inc $ 1,209 $ 13 $ -87 -
Fate Therapeutics Inc $ 115 $ 4 $ -35 -
Aerie Pharmaceuticals Inc $ 1,831 - $ -102 -
Coherus Biosciences, Inc. $ 643 $ 189 $ -127 -
Atara Biotherapeutics, Inc. $ 442 - $ -88 -
Capricor Therapeutics, Inc. $ 28 $ 4 $ -18 -
Xenetic Biosciences, Inc. $ 26 - $ -58 -
Twinlab Consolidated Holdings, Inc. $ 177 $ 90 $ 0 -
Applied Genetic Technologies Corp $ 86 $ 43 $ 8 -
Mount Tam Biotechnologies, Inc. $ 7 - $ -2 -
Genocea Biosciences, Inc. $ 174 - $ -54 -
Kite Pharma, Inc. $ 5,644 $ 27 $ -314 -
Assembly Biosciences, Inc. $ 368 - $ -47 -
Gtx Corp $ 2 $ 1 $ -1 -
Mabvax Therapeutics Holdings, Inc. $ 6 - $ -19 -
Proteon Therapeutics Inc $ 22 - $ -28 -
Ampliphi Biosciences Corp $ 1 $ 0 $ -23 -
Hedgepath Pharmaceuticals, Inc. $ 168 - $ -9 -
Sevion Therapeutics, Inc. $ 7 - $ -5 -
Enumeral Biomedical Holdings, Inc. $ 1 $ 5 $ -12 -
Fennec Pharmaceuticals Inc. $ 80 - $ -3 -
Cannapharmarx, Inc. $ 6 - $ -11 -
Avalanche Biotechnologies, Inc. $ 112 $ 2 $ -53 -
Axim Biotechnologies, Inc. $ 431 $ 0 $ -4 -
Cidara Therapeutics, Inc. $ 133 - $ -52 -
Tracon Pharmaceuticals, Inc. $ 37 $ 3 $ -28 -
Juno Therapeutics, Inc. $ 2,974 $ 89 $ -257 -
Spark Therapeutics, Inc. $ 2,163 $ 20 $ -150 -
N-viro International Corporation $ 0 - $ -1 -
Nascent Biotech Inc. $ 7 - $ 1 -
Myokardia Inc $ 488 $ 41 $ -19 -
Tobira Therapeutics, Inc. $ 792 - $ -15 -
Immage Biotherapeutics Corp. $ 3 - $ -2 -
Cardax, Inc. $ 18 - $ -2 -
Cocrystal Pharma, Inc. $ 143 - $ -73 -
Mymetics Corp - $ 1 $ -7 -
Pulmatrix, Inc. $ 39 - $ -26 -
Aytu Bioscience, Inc $ 4 $ 3 $ -33 -
Nantkwest, Inc. $ 541 $ 0 $ -115 -
Sangui Biotech International Inc $ 4 $ 0 $ 0 -
Oncbiomune Pharmaceuticals, Inc $ 6 - $ -4 -
Cytomx Therapeutics, Inc. $ 505 $ 24 $ -51 -
Dna Testing Centers Corp $ 0 $ 0 $ 0 -
Catalyst Biosciences, Inc. $ 4 $ 1 $ -17 -
Regenxbio Inc. $ 500 $ 5 $ -74 -
Integrated Biopharma Inc $ 6 $ 47 $ 2 -
Wave Life Sciences Ltd. $ 472 $ 2 $ -69 -
Dimension Therapeutics, Inc. $ 31 $ 13 $ -53 -
Tyme Technologies, Inc. $ 332 - $ -15 -
Nugene International, Inc. $ 2 $ 1 $ -12 8
Mirna Therapeutics, Inc. $ 35 - $ -25 -
Cerecor Inc. $ 8 - $ -17 -
Strongbridge Biopharma Plc $ 231 - $ -62 -
Immune Therapeutics, Inc. $ 12 - $ -15 -
Respirerx Pharmaceuticals Inc. $ 3 - $ -8 -
Premier Biomedical Inc $ 2 - $ -2 -
Kubota Pharmaceutical Holdings Co Ltd $ 354 - $ -31 -
General Cannabis Corp $ 52 $ 3 $ -29 -
Oxis International Inc $ 1 - $ -7 -
Soligenix, Inc. $ 13 $ 9 $ -4 -
Eiger Biopharmaceuticals, Inc. $ 74 - $ 0 -
Uluru Inc. $ 4 $ 1 $ -4 -
Opiant Pharmaceuticals, Inc. $ 29 $ 5 $ 3 -
Edge Therapeutics, Inc. $ 309 - $ -42 -
Guided Therapeutics Inc $ 0 $ 0 $ -4 -
Boston Therapeutics, Inc. $ 4 $ 0 $ -4 -
Proteo Inc $ 1 $ 0 $ 0 -
Pharmacyte Biotech, Inc. $ 72 - $ -4 -
Skinvisible Inc $ 2 $ 0 $ -2 -
Pivot Pharmaceuticals Inc. $ 8 - $ -3 -
Endonovo Therapeutics, Inc. $ 6 - $ -12 -
Alliance Bioenergy Plus, Inc. $ 14 - $ -9 -
Mj Pharmaceuticals Inc. $ 20 - $ 0 -
Entia Biosciences, Inc. $ 1 $ 0 $ -1 -
Therapeutic Solutions International, Inc. $ 6 $ 0 $ -1 -
Global Future City Holding Inc. $ 9 $ 3 $ -5 -
United Cannabis Corp $ 44 $ 1 $ -2 -
Aviragen Therapeutics, Inc. $ 21 $ 4 $ -18 -
Relmada Therapeutics, Inc. $ 10 - $ -8 -
Green Meadow Products, Inc. $ 80 $ 0 $ 0 -
Aclaris Therapeutics, Inc. $ 625 - $ 0 -
Voyager Therapeutics, Inc. $ 242 $ 11 $ 31 -
Citius Pharmaceuticals, Inc. $ 382 - $ -11 1
Dandrit Biotech Usa, Inc. $ 17 - $ -3 -
Syndax Pharmaceuticals Inc $ 237 $ 1 $ -49 -
Proteostasis Therapeutics, Inc. $ 77 $ 8 $ -44 -
Adaptimmune Therapeutics Plc $ 2,295 $ 14 $ -78 -
Aeolus Pharmaceuticals, Inc. $ 13 $ 1 $ -4 -
Taxus Pharmaceuticals Holdings, Inc. $ 269 - $ 0 -
Intellia Therapeutics, Inc. $ 577 $ 21 $ -38 -
Axovant Sciences Ltd. $ 2,221 - $ -181 -
Biotech Products Services & Research, Inc. $ 3 $ 0 $ -8 -
Vistagen Therapeutics, Inc. $ 43 - $ 0 -
Oncobiologics, Inc. $ 23 - $ -24 -
Pulse Biosciences, Inc. $ 345 $ 0 $ -11 -
Adverum Biotechnologies, Inc. $ 107 $ 0 $ -16 -
Windtree Therapeutics Inc $ 2 $ 0 $ -9 -
Audentes Therapeutics, Inc. $ 431 - $ -18 -
Protagonist Therapeutics, Inc $ 218 - $ -14 -
Aptevo Therapeutics Inc. $ 39 $ 7 $ -10 -
Rasna Therapeutics Inc. $ 250 - $ 0 -
Nexus Biopharma Inc - - $ 0 -
Obalon Therapeutics Inc $ 140 - $ 0 -
Fulgent Genetics, Inc. $ 120 - $ 0 -
Mateon Therapeutics Inc $ 8 - $ 0 -
Vitality Biopharma, Inc. $ 25 - $ 0 -
Compass Biotechnologies Inc. $ 0 - $ 0 -
Aevi Genomic Medicine, Inc. $ 46 - $ 0 -
Crispr Therapeutics Ag $ 702 - $ 0 -
Azurrx Biopharma, Inc. $ 44 - $ 0 -
Jounce Therapeutics, inc. $ 306 - $ 0 -
Biotechnology & Drugs Industry $ 623,441 $ 109,469 $ 35,925 69,064
Earnings Earnings Earnings
Earnings Outlook increase
Looking into earnings estimates within the Biotechnology & Drugs Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Biotechnology & Drugs Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates.
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Biotechnology & Drugs Industry.
Earnings Estimates decrease
Pessimism dominates within Biotechnology & Drugs Industry, as most of the businesses cut their earnings guidance, staggering 66.67 % have revised down earnings outlook. Overall earnings expectations for the Biotechnology & Drugs Industry were cut by %, to the annual earnings expectation of %.
Expected Eps Growth Eps Expectation Revision
n   %     Industry Expected EPS Growth
Total Ranking # Within Sector #
n   %   Industry Earnings Outlook Revision
Total Ranking # Within Sector #
Revenue Revenue Revenue
Sales Forecast increase
In the current quarter 66.67 % of companies, who have issued revenue expectation within Biotechnology & Drugs Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year.
Sales Expectations unchanged
Among companies who provide sales guidance within Biotechnology & Drugs Industry 33.33 %, have reiterated own sales estimates for the current fiscal year.
Sales Outlook decrease
In Biotechnology & Drugs Industry, there were no sales guidance decreases
Expected Revenue Growth Revenue Expectation Revision
  %     Industry Expected Revenue Growth
Total Ranking # Within Sector #
  %   Industry Revenue Outlook Revision
Total Ranking # Within Sector #

Cardiovascular Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com